MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$12,581,600
Net loss
-$12,494,260
Foreign currency
translation loss
-$87,340
Interest income, net
$180,246
Operating loss
-$12,642,136
Other income
(expense), net
-$32,370
General and
administrative
$6,729,817
Research and development
$5,757,487
Change in fair value of
related party note
$154,832
Back
Back
Income Statement
source: myfinsight.com
MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics, Inc. (INKT)